Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Prestige Consumer Healthcare Inc.    PBH

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

11/05/2020 | 06:11am EST

Item 2.02 Results of Operations and Financial Condition.

On November 5, 2020, Prestige Consumer Healthcare Inc. (the "Company") announced financial results for the fiscal quarter and six months ended September 30, 2020. A copy of the press release announcing the Company's earnings results for the fiscal quarter and six months ended September 30, 2020 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On November 5, 2020, representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter and six months ended September 30, 2020 using slides attached to this Current Report on Form 8-K as Exhibit 99.2 (the "Investor Presentation") and incorporated herein by reference. The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2021.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

The information presented in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

See Exhibit Index immediately following the signature page.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about PRESTIGE CONSUMER HEALTHCARE INC.
01/12PRESTIGE CONSUMER HEALTHCARE : ICR Conference 2021 Presentation
PU
01/08Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnin..
GL
2020DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $..
MT
2020Prestige Consumer Healthcare Fiscal Q2 Adjusted Profit, Revenue Top Expectati..
MT
2020PRESTIGE BRANDS : Fiscal 2Q Earnings Snapshot
AQ
2020PRESTIGE CONSUMER HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
2020PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Conditio..
AQ
2020PRESTIGE CONSUMER HEALTHCARE : Reports Fiscal 2021 Second Quarter Results
AQ
2020Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results
GL
2020PRESTIGE CONSUMER HEALTHCARE : to Release Fiscal 2021 Second Quarter Earnings Re..
AQ
More news
Financials (USD)
Sales 2021 927 M - -
Net income 2021 164 M - -
Net Debt 2021 - - -
P/E ratio 2021 11,6x
Yield 2021 -
Capitalization 1 880 M 1 880 M -
Capi. / Sales 2021 2,03x
Capi. / Sales 2022 2,00x
Nbr of Employees 520
Free-Float 92,2%
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 42,75 $
Last Close Price 37,52 $
Spread / Highest target 27,9%
Spread / Average Target 13,9%
Spread / Lowest Target -1,39%
EPS Revisions
Managers and Directors
NameTitle
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Jeff Zerillo Senior Vice President-Operations
Christine Sacco Chief Financial Officer
John E. Byom Independent Director
Gary E. Costley Lead Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PRESTIGE CONSUMER HEALTHCARE INC.7.60%1 880
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993